Coronavirus III: What is to be done?

We live in evolutionary competition with microbes — bacteria and viruses.  There is no guarantee that we will be the survivors. The aphorism from Joshua Lederberg, a founder of molecular biology, is remarkable for its humility and for the challenge it defines. Before the germ theory of disease, which appeared in the second half of the 19th century, medicine was helpless against infection. We have since become good at preventing and treating many infections, so it is galling that we remain stymied in our battle with COVID-19.

The natural world creates new viral genomes by mutation or exchange between two viruses. Some of these viruses escape the surveillance of human immune systems and spread as epidemics or pandemics. What the natural world can mount in the way of threats is greater than anything we could build ourselves, but when a new disease appears, we have an innate tendency to blame other humans, as if nature could not be so clever.  Thus, President Trump and Secretary Pompeo have been blaming the Chinese. But Chinese virologists did not make SARS-CoV2. 

The genome of SARS-CoV2 is almost 30,000 nucleotides long and is arranged in a code that can be translated into the proteins of SARS-CoV2.  On Jan. 9, Chinese virologists deposited the sequence in GenBank, the NIH-sponsored resource for the world’s scientific and medical communities. It had taken them 10 days to sequence and analyze the genome. From that sequence, skilled virologists can make vaccines and begin other studies. Two and a half months into the pandemic, the flow of scientific reports on COVID-19 has become a reassuring flood. 

That the Wuhan Institute of Virology deposited the sequence so fast is not the act of people hiding information. Perhaps the more regressive and suspicious functionaries of the Chinese Government, who had already chastised Dr. Li Wenliang (who described the syndrome and then died from it), probably knew nothing about GenBank. Perhaps (purely my guess) the critical sequence information slipped by them, like a fastball low and away.

How did the pandemic develop? Imagine a person with COVID-19 who infects between two and three other people. Thus R naught is 2-3, compared to flu at 1.3 to 1.4. If everyone is taking maximum precautions, they are both much less. Social distancing, hand washing and staying at home reduce R naught. A good vaccine could reduce it to nearly zero, but that is months away. 

The COVID-19 coronavirus produces many copies of itself that exit a lung cell in little blisters. If replication of the virus is not slowed, the inflammation and cellular destruction that result cause the blood vessels around the alveoli of the lungs to leak. Liquid and the defensive cells of the immune system fill these air sacs and breathing becomes difficult without supplemental oxygen and often a ventilator. Some people recover, but ventilation is often a long haul.

Between now and the appearance of new vaccines, the best we can do, beyond isolation, is to find drugs that slow the virus infection and protect front-line medical staff. There will probably be a new surge of virus in the fall and it would be criminal to ask nurses, doctors and others to return to emergency rooms without much better protection than they have had. 

Drugs that slow viruses similar to SARS-CoV2 exist, and are entering clinical trials quickly. Some, like hydroxyquinoline, don’t work and have been abandoned. Remdesivir blocks the production of the RNA genomes for new viruses. More trials are necessary according to Dr. Anthony Fauci, for whom this is familiar territory from the battle against HIV. Tests of dosage and early use in the course of an infection may make remdesivir more effective. Another drug, baricitinib, blocks the cytokine storms and inflammation that occur days after infection. The NIH is beginning a clinical trial that asks whether the two drugs have additive benefits. Many such experimental treatments with other drugs are being done around the world (see www.ClinicalTrials.gov). 

Prof. Arturo Casadevall of The Johns Hopkins Bloomberg School of Public Health speaks of layered defenses. What he has in mind is the convalescent antisera of people who have recovered from COVID-19. Francis Collins, Director of the NIH, has noted that almost all patients who have recovered from COVID-19 have circulating antibodies to the virus. This approach to stopping the virus by supplying such antibodies to the circulation has entered clinical trials in the United Kingdom and will soon be in double-blind trials in the United States. Anecdotal evidence (a scientific oxymoron) says that Italian patients benefited. 

It is good to use a layered defense, trying all therapies because there will be a COVID-25, a pandemic flu strain, or a respiratory form of Ebola virus in our future. In this pandemic, we have not performed brilliantly up to now. Science and organization count and we should reinforce them — a lot.

Richard Kessin is Professor Emeritus of Pathology and Cell Biology at the Columbia University Irving Medical Center. He lives in Norfolk and can be reached at Richard.Kessin@gmail.com.

The views expressed here are not necessarily those of The Lakeville Journal and The Journal does not support or oppose candidates for public office.

Latest News

Remembering George and Anne Phillips’ Edgewood restaurant in Amenia

The Edgewood Restaurant, a beloved Amenia roadside restaurant run by George and Anne Phillips, pictured during its peak years in the 1950s and ’60s.

Provided

With the recent death of George Phillips at 100, locals are remembering the Edgewood Restaurant, the Amenia supper club he and his wife, Anne Phillips, owned and operated together for more than two decades.

At the Edgewood, there were Delmonico steaks George carved in the basement, lobster tails from an infrared cooker, local trout from the stream outside the door, and a folded paper cup of butter, with heaping bowls of family-style potatoes and vegetables, plus a shot glass of crème de menthe to calm the stomach when the modest check arrived after dessert.

Keep ReadingShow less
Artist Alissa DeGregorio brings her work to Roxbury and New Milford

Alissa DeGregorio, a New Milford -based artist and designer, has pieces on display at Mine Hill Distillery.

Agnes Fohn
When I’m designing a book, I’m also the bridge between artist and author, the final step that pulls everything together.
— Alissa DeGregorio

A visit to Alissa DeGregorio Art, the website of the artist and designer, reveals the multiple talents she possesses.

Tabs for design, commissions, print club, and classes still reveal only part of her work.On the design page are examples of graphic and book design, including book covers illustrated by DeGregorio, along with samples of licensed products such as coloring pages and lunch boxes, and examples of prop design she has done for film.

Keep ReadingShow less

Agnes Martin at Dia:Beacon

Agnes Martin at Dia:Beacon

Minimalist works by Agnes Martin on display at Dia:Beacon.

D.H. Callahan

At Dia:Beacon, simplicity commands attention.

On Saturday, April 4, the venerated modern art museum — located at 3 Beekman St. in Beacon, NY — opened an exhibition of works by the middle- to late-20th-century minimalist artist Agnes Martin.

Keep ReadingShow less
google preferred source

Want more of our stories on Google? Click here to make us a Preferred Source.

Falls Village exhibit honors life and work of Priscilla Belcher

Hunt Library in Falls Village will present a commemorative show of paintings and etchings by the late Priscilla Belcher of Falls Village.

Lydia Downs

Priscilla Belcher, a Canaan resident who was known for her community involvement and willingness to speak out, will be featured in a posthumous exhibition at the ArtWall at the Hunt Library from April 25 through May 15.

An opening reception will be held from 5 to 7 p.m. on April 25. The show will commemorate her life and work and will include watercolors and etchings. Belcher died in November 2025 at the age of 95.

Keep ReadingShow less
Crescendo’s 'Stepping Into Song' blends Jewish, Argentine traditions

The sounds of Argentine tango and Jewish folk traditions will collide in a rare cross-cultural performance April 25 and 26, when Berkshire’s Crescendo presents the choral program “Stepping Into Song.”

Christine Gevert, Crescendo’s founding artistic director, described the concert as “a world-class, diverse cultural experience” pairing “A Jewish Cantata” with Martin Palmeri’s “Misa a Buenos Aires.”

Keep ReadingShow less
Salisbury Rotary brings Derby race-day flair to Noble Horizons for community fundraiser
Salisbury Rotary Club President Bill Pond and his wife, Beth, dressed for the occasion during last year’s Kentucky Derby Social.
Provided

SALISBURY — As millions tune in to the Kentucky Derby at Churchill Downs on May 2, a spirited local tradition unfolds in Salisbury, where the pageantry, fashion and excitement of race day are recreated — with a community purpose.

For the past six years in the Community Room at Noble Horizons, all eyes turn to the big screen as the crowd settles in, drinks in hand and anticipation building. Women in elaborate Derby hats — bursting with oversized silk flowers, feathers and playful cutouts — mingle with men dressed for the occasion in crisp jackets and bow ties, fedoras and the occasional red rose on a lapel.

Keep ReadingShow less
google preferred source

Want more of our stories on Google? Click here to make us a Preferred Source.

google preferred source

Want more of our stories on Google? Click here to make us a Preferred Source.